Medication info
Megalosutin Tablet 2.5 mg (Rosuvastatin Calcium)

Megalosutin Tablet 2.5 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›2.6mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202401442 · Approved 2024.06.13 · Insurance code 060500960

Summary

Main use
Improvement of primary hypercholesterolemia and mixed hyperlipidemia
Who uses it
Adults
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. Older adults: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this drug to patients with moderate renal impairment. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. Race: Since systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • familial heterozygous hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication is used for primary hypercholesterolemia and mixed dyslipidemia. These conditions occur mainly when cholesterol and lipid levels in the blood are elevated and are not controlled by diet and exercise alone. It is particularly effective for patients with genetic hypercholesterolemia such as familial heterozygous hypercholesterolemia. Therefore, this medication is used as an adjunct to diet to improve blood lipid levels.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. Older adults: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this drug to patients with moderate renal impairment. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. Race: Since systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Precautions

This medication should not be administered to certain patients. For example, patients with allergies to this medication, severely impaired liver function, muscle diseases, significantly reduced kidney function, women who are pregnant or breastfeeding, and women of childbearing age who are not using adequate contraception should not take this medication. Additionally, high-dose administration of this medication is contraindicated in patients at high risk for myopathy or rhabdomyolysis. Risk factors include moderate kidney dysfunction, hypothyroidism, a history of genetic muscle disorders, alcohol abuse, and concurrent use of certain medications. This medication contains lactose, so patients with lactose intolerance should also avoid taking it. While taking this medication, attention should be paid to liver function, and patients with a history of liver disease or heavy alcohol consumption require regular liver enzyme checks. Furthermore, if symptoms such as muscle pain or weakness arise, healthcare personnel should be informed immediately, and blood tests should be performed if necessary to check for muscle damage. This medication can interact with other drugs, so it is essential to inform healthcare personnel of any current medications being taken. Caution is particularly needed when taken in conjunction with certain antibiotics, antifungals, immunosuppressants, and fibrate-class drugs. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraception. In case of overdose, there is no specific antidote; treatment will depend on symptoms, along with checks on liver function and muscle enzymes. Finally, this medication may cause side effects such as dizziness, so caution is advised when driving or operating machinery.

Side effects

Dyspepsia, pruritus, immune thrombocytopenic purpura, facial swelling, herpes zoster, vulvar pruritus, hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, generalized exanthematous pustulosis, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it is safe to store it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication over time.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.